Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 2015 Dec 8;21(1):665. doi: 10.2119/molmed.2015.00139.erratum

Erratum

PMCID: PMC4749492

The following paper had incorrect IC50 values in Table 1; the values should be the same as given in Table 2:

Davorka Messmer, Kymmy Lorrain, Karin Stebbins, Yalda Bravo, Nicholas Stock, Geraldine Cabrera, Lucia Correa, Austin Chen, Jason Jacintho, Nicholas Chiorazzi, Xiao Jie Yan, David Spaner, Peppi Prasit, and Daniel Lorrain. (2015) A Selective Novel Peroxisome Proliferator–Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo. Mol. Med. 21:410–9.

Table 1 with incorrect values is below.

Table 1.

IC50 values (inhibition in antagonist mode) for human PPARα, PPARδ and PPARγ.

Human PPAR NXT629
Inline graphic
NXT962
Inline graphic
PPARα 78 nmol/L >15,000 nmol/L
PPARδ >30,000 nmol/L >30,000 nmol/L
PPARγ >30,000 nmol/L >30,000 nmol/L

Table 1 with correct values is below.

Table 1.

IC50 values (inhibition in antagonist mode) for human PPARα, PPARδ and PPARγ.

Human PPAR NXT629
Inline graphic
NXT962
Inline graphic
PPARα 77 nmol/L >30,000 nmol/L
PPARδ 6,000 nmol/L >30,000 nmol/L
PPARγ 15,000 nmol/L >30,000 nmol/L

Footnotes

Online address: http://www.molmed.org


Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES